<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Biol Chem. 1999 December 31; 274(53): 37781&#226;&#8364;&#8220;37786. <br />  <br />  <br />  <br />                            Essential Protein-Protein Interactions Plasmodium <br />                            falciparum Thymidylate Synthase Dihydrofolate Reductase <br />                            Domains* <br />                            Shamira Shallom, Kai Zhang, Lei Jiang, Pradipsinh K. Rathod&#226;&#8364;&#161; <br />                            Department Biology, The Catholic University America, Washington, D. C. 20064 <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                 In Plasmodium falciparum, dihydrofolate reductase thymidylate synthase activities are <br />                                 conferred single 70-kDa bifunctional polypeptide (DHFR-TS, dihydrofolate reductase- <br />                                 thymidylate synthase) assembles functional 140-kDa homodimer. In mammals, the <br />                                 enzymes smaller distinct molecules encoded different genes. A 27-kDa amino domain <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 malarial DHFR-TS sufficient provide DHFR activity, structural requirements for <br />                                 TS function established. Although 3&#226;&#8364;&#178;-end DHFR-TS high homology <span id='am-5' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                 TS sequences species, expression protein fragment failed yield active TS <br />                                 enzyme, failed complement TS&#226;&#710;&#8217; Escherichia coli. Unexpectedly, partial 5&#226;&#8364;&#178;-deletion <br />                                 full-<span id='am-4' about='xsp:length' typeof='owl:Thing'>length</span> DHFR-TS gene abolished TS function 3&#226;&#8364;&#178;-end. Thus, hypothesized that <br />                                 amino end bifunctional parasite protein plays important role TS function. When <br />                                 27-kDa amino domain (DHFR) provided trans, previously inactive 40-kDa carboxyl- <br />                                 domain malarial DHFR-TS regained TS function. Physical characterization &#226;&#8364;&#339;split <br />                                 enzymes&#226;&#8364;? revealed 27- 40-kDa fragments DHFR-TS reassembled a <br />                                 140-kDa hybrid complex. Thus, malarial DHFR-TS, physical interactions the <br />                                 DHFR domain TS domain, interactions necessary obtain catalytically <br />                                 active TS. Interference essential protein-protein interactions lead new selective <br />                                 strategies treat malaria resistant traditional DHFR-TS inhibitors. <br />  <br />                                              Malaria, caused protozoan parasite Plasmodium falciparum, affects 300 million <br />                                              individuals causes 2 million death year (1). Traditional antimalarial agents <br />                                              chloroquine ineffective regions world drug resistance (2, <br />                                              3). In addition, mounting evidence highly drug-resistant parasite clones acquire <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              resistance new antimalarial agents enhanced rate (4, 5). Identification host- <br />                                              parasite biochemical differences lead selective chemotherapy important <br />                                              before. <br />  <br />                                              In malaria cell types, chemotherapy targeted dihydrofolate <br />                                              reductase (DHFR)1 thymidylate synthase (TS) proven highly effective (6, 7). <br />                                              Even partial inhibition DHFR TS lead DNA strand fragmentation cell death <br />                                              (8 &#226;&#8364;&#8220;10). In malaria pharmacology, enzymes particular because <br />  <br />  <br />                            *This work supported United States Public Health Service Grants AI26912 AI40956 National Institutes of <br />                            Health. <br />                            &#194;&#169; 1999 The American Society Biochemistry Molecular Biology, Inc. <br />                            To correspondence addressed: Dept. Biology, The Catholic University America, 620 Michigan Ave., N.E., <br />                            Washington D. C. 20064. Tel.: 202-319-5278; Fax: 202-319-5721; rathod@cua.edu. <br />                            &#226;&#8364;&#161;Recipient Burroughs Wellcome Fund New Initiatives Malaria Research award. <br />                            1The abbreviations used are: DHFR, dihydrofolate reductase; TS, thymidylate synthase. <br />                             Shallom et al.                                                                                            Page 2 <br />  <br />  <br />                                             traditional drugs pyrimethamine cycloguanil known inhibit parasite <br />                                             DHFR-TS (11&#226;&#8364;&#8220;13). In recent years, however, effectiveness inhibitors been <br />                                             compromised malarial parasite strains expressing mutant forms DHFR-TS (14 &#226;&#8364;&#8220;16). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             One obvious way continue selective killing malarial parasites identify new folate <br />                                             analogs directed DHFR- TS-active sites effective drug-resistant <br />                                             parasites (17&#226;&#8364;&#8220;20). <br />  <br />                                             Beyond active site-directed strategies, non-traditional opportunities inhibit <br />                                             malarial DHFR-TS selectivity. All protozoan parasites, including Plasmodia, a <br />                                             single bifunctional protein codes DHFR TS activity (21&#226;&#8364;&#8220;24). In sharp <br />                                             contrast, mammalian cells (as bacteriophage, bacteria, yeast) separate <br />                                             genes <span id='am-3' about='Thesaurus:code' typeof='owl:Thing'>code</span> small monofunctional DHFR TS proteins (25, 26). This difference in <br />                                             organization established drug targets represents dramatic difference host- <br />                                             parasite biochemistry. Yet, clear bifunctional status DHFR-TS <br />                                             play role selective chemotherapy. First, indications active sites of <br />                                             DHFR TS bifunctional proteins operate independently other. Inhibition <br />                                             DHFR methotrexate does influence TS activity, inhibition TS function <br />                                             5-fluoro-2&#226;&#8364;&#178;-deoxyuridylate does effect DHFR activity (27). The structure of <br />                                             Leishmania DHFR-TS suggests active sites DHFR-TS 40 &#195;&#8230; apart (28). <br />                                             Designing &#226;&#8364;&#339;double-barrel,&#226;&#8364;? parasite-specific bifunctional DHFR-TS inhibitor a <br />                                             practical goal present. Second, kinetic measurements suggest Leishmania and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Toxoplasma TS channel 8 10 dihydrofolate (DHF) molecules directly <br />                                             TS site DHFR site (27, 29, 30). Indeed, Leishmania DHFR-TS structure <br />                                             indicates direct channeling attributed electropotential gradient the <br />                                             bifunctional protein leads TS folate-binding site DHFR folate-binding <br />                                             site (28, 29). However, highly unlikely blocking channeling lead to <br />                                             selective antimalarial chemotherapy malarial DHFR-TS active sites any <br />                                             trouble delivering accepting substrates bulk solvent vitro (31, 32) vivo <br />                                             (33). <br />  <br />                                             In study, demonstrate species-specific interactions malarial DHFR <br />                                             domain TS domain essential functioning enzymes. Inhibition such <br />                                             protein-protein interactions offer powerful new strategy selective chemotherapy <br />                                             malaria possibly protozoan parasites. <br />  <br />                               EXPERIMENTAL PROCEDURES <br />                               Materials <br />                                             Trimethoprim, ampicillin, tetracycline, leucine, proline, thymidine, 2&#226;&#8364;&#178;-deoxyuridylate, 5- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             fluoro-2&#226;&#8364;&#178;-deoxyuridylate, dihydrofolate, methotrexate-agarose Sigma. <br />                                             Oligonucleotides synthesized Operon (Alameda, CA). Escherichia coli strains <br />                                             BL21, BL21(DE3), DE3 lysogenization kit Novagen (Madison, WI). E. <br />                                             coli strain Rue10 (thyA&#226;&#710;&#8217;) Chen-Chen Kan (Agouron Pharmaceuticals). <br />  <br />                               Plasmids <br />                                             Plasmid pKK233.2 P. falciparum DHFR-TS coding sequence clone K1 was <br />                                             obtained John Hyde (University Manchester) maintained described <br />                                             previously (34). Plasmids pET23d(+) <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> Novagen (Madison, WI). This plasmid <br />                                             cut NcoI HindIII modified express different domains P. falciparum <br />                                             DHFR-TS (Fig. 1). pET-DHFR designed express amino acids 1&#226;&#8364;&#8220;230 P. <br />                                             falciparum DHFR-TS coding region (32, 34); pET-TS31 expressed amino acids 325&#226;&#8364;&#8220; 607 of <br />                                             the P. falciparum DHFR-TS coding region; pET-TS40 coded amino acids 249 &#226;&#8364;&#8220; 607 <br />  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                           Page 3 <br />  <br />  <br />                                             P. falciparum DHFR-TS coding region, pET-DHFR-TS contained full-length <br />                                             coding region (Fig. 1). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Antibody P. falciparum DHFR Domain <br />                                             The antigen, malarial DHFR domain, expressed purified methotrexate-affinity <br />                                             column described previously (32). Rabbit polyclonal antibodies pure protein were <br />                                             raised Josman Laboratories (Napa, CA). P. falciparum DHFR-specific antibody was <br />                                             purified affinity chromatography using P. falciparum DHFR domain attached to <br />                                             Aminolink Plus Pierce. <br />  <br />                               Genetic Complementation Assay TS Function <br />                                             The thymidylate synthase-deficient E. coli strain Rue10 lysogenized &#206;&#187;DE3 to <br />                                             provide T7 RNA polymerase function host (36). The host cells maintained in <br />                                             LB medium presence leucine (40 &#206;&#188;g/ml), proline (200 &#206;&#188;g/ml), thymidine (100 <br />                                             &#206;&#188;g/ml). When testing TS function pET plasmids bearing malarial DHFR-TS gene, or <br />                                             portions gene, 50 ng plasmid electroporated 4 &#195;&#8212; 107 <br />                                             electrocompetent Rue10(DE3) cells. The cells spread sets ampicillin agar <br />                                             plates, thymidine lacking thymidine. <br />  <br />                               Genetic Complementation Assay Malarial DHFR Function <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Appropriate pET plasmids electroporated BL21(DE3) cells above. These cells <br />                                             spread sets ampicillin agar plates, trimethoprim (50 &#206;&#188;g/ml) and <br />                                             without. Bacterial DHFR sensitive trimethoprim malarial DHFR (34). <br />  <br />                               Exonuclease Treatment DNA Fragment Coding Malarial DHFR-TS <br />                                             The 5&#226;&#8364;&#178;-deletion experiment involved following steps prior testing TS <br />                                             function: (i) generation DNA strand malarial DHFR-TS sequence was <br />                                             susceptible exonuclease 5&#226;&#8364;&#178;-end 3&#226;&#8364;&#178;-end; (ii) digestion long <br />                                             fragment exonuclease varying amounts time generate series short DNA <br />                                             fragments varying length; (iii) preparation recipient vector AUG start codon; <br />                                             (iv) ligation short partially digested fragments recipient vector. <br />  <br />                                             Initially, 12 &#206;&#188;g pET23d(+) plasmid full-length malarial DHFR-TS insert was <br />                                             digested 24 units PvuII 24 units PstI total volume 40 &#206;&#188;l 6 h. The <br />                                             purified 3900-<span id='am-6' about='xsp:base' typeof='owl:Thing'>base</span> pair fragment containing DHFR-TS sequence susceptible to <br />                                             exonuclease III PvuII end PstI end. To initiate digestion 5&#226;&#8364;&#178;-end, 6 <br />                                             &#206;&#188;g DNA placed 60 &#206;&#188;l ExoIII buffer (Erase-abase kit, Promega, Madison, WI). <br />                                             A 2.5-&#206;&#188;l aliquot removed time 0. Digestion started 400 units exonuclease <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             III delivered 2.3-&#206;&#188;l volume. Under conditions, digestion occurred rate 80 &#226;&#8364;&#8220;90 <br />                                             base pairs min 22&#226;&#8364;&#8220;25 &#194;&#176;C. Aliquotes 2.5 &#206;&#188;l removed 2.5 min 60 min. <br />                                             These treated S1 nuclease blunt-ended Klenow described (Erase-a- <br />                                             base kit, Promega, Madison, WI). A cohesive end the 3&#226;&#8364;&#178;-end DHFR-TS coding <br />                                             region generated treating 2.5-min samples HindIII. <br />  <br />                                             A recipient plasmid expressing exonuclease-treated DNA generated first <br />                                             cutting 5 &#206;&#188;g pET23d(+) 6 units NcoI. The NcoI-digested plasmid blunt-ended <br />                                             Klenow (10 units, room temperature, 14 min) digested HindIII (24 units, <br />                                             37 &#194;&#176;C, 4 h) generate cohesive site end vector. Approximately 760 ng <br />                                             exonuclease-digested DNA (5 &#206;&#188;l) ligated 312 ng recipient vector. The ligation <br />                                             products 2.5-min time point transformed electrocompetent <br />                                             Rue10(DE3) cells plated thymidine measure TS function, ligated DNA <br />  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                          Page 4 <br />  <br />  <br />                                             transformed electrocompetent BL21(DE3) cells plated trimethoprim plates <br />                                             measure DHFR function (see above). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Co-transformation E. coli Rue10(DE3) Two Plasmids Coding DHFR Fragment <br />                               TS Fragment <br />                                             In step, pET-DHFR transformed Rue10(DE3) selected ampicillin <br />                                             resistance. These Rue10(DE3)pET-DHFR electrocompetent, transformed with <br />                                             pET-TS40, selected growth medium lacking thymidine. Subsequently, was <br />                                             double transformants obtained transforming cells pET- <br />                                             TS40 (selection ampicillin plates) transforming pET-DHFR <br />                                             (selection medium thymidine). <br />  <br />                               Physical Characterization P. falciparum TS40 + DHFR Split Protein <br />                                             E. coli Rue10(DE3), co-transformed pET-DHFR pET-TS40, freshly grown to <br />                                             absorbance 1.0 600 nm. The cells collected centrifugation resuspended <br />                                             50 mM Tris-HCl, pH 8, 2 mM EDTA, 0.1% Triton X-100, 0.1 mg/ml lysozyme (final <br />                                             lysis volume 1/10 original culture volume). The cells incubated 30 &#194;&#176;C for <br />                                             15 min, sonicated, stored 1-ml aliquots &#226;&#710;&#8217;20 &#194;&#176;C. <br />  <br />                                             To estimate native size DHFR TS activities gel filtration chromatography, <br />                                             200 &#206;&#188;l cell lysate applied 1 &#195;&#8212; 50 cm Superdex 200 column <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             (Amersham Pharmacia Biotech). The buffer gel filtration 50 mM Tris-HCl, pH 8, 2 <br />                                             mM EDTA, 10% glycerol, 0.1 M NaCl, 2 mM dithiothreitol. The flow rate 0.25 ml/min, <br />                                             0.5-ml fractions collected. <br />  <br />                                             The split protein purified homogeneity using methotrexate affinity chromatography. <br />                                             A total 10 ml cell lysate double-transformed E. coli Rue10(DE3) applied <br />                                             2-ml methotrexate-agarose column pre-equilibrated 50 mM Tris-HCl, pH 8, 2 mM <br />                                             EDTA, 10% glycerol, 0.5 M NaCl, 2 mM dithiothreitol. The column washed with <br />                                             20 ml equilibration buffer active fractions eluted buffer <br />                                             plus 4 mM dihydrofolate. One-ml fractions collected. <br />  <br />                               Assay TS Activity Malarial DHFR Protein <br />                                             After chromatography step, malarial TS activity monitored assaying 10 &#206;&#188;l of <br />                                             fraction using 5-[3H]-2&#226;&#8364;&#178;deoxyuridylate tritium release assay (34). Malarial DHFR <br />                                             activity monitored Western blotting fraction. A 10-&#206;&#188;l sample tube <br />                                             applied 10% SDS-polyacrylamide gel electrophoresis system. After <br />                                             separation, protein transferred polyvinylidene difluoride membrane. Malarial <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             DHFR detected using affinity purified polyclonal antibodies malarial DHFR domain <br />                                             (see above), goat anti-rabbit secondary antibodies, Western-Star chemiluminescent <br />                                             detection (Tropix, Inc., Bedford, MA). This assay easily detected 1 ng malarial <br />                                             DHFR. <br />  <br />                               RESULTS AND DISCUSSION <br />                               The Carboxyl End Malarial DHFR-TS Is Insufficient TS Function <br />                                             The amino-terminal DHFR domain malarial DHFR-TS expressed functional <br />                                             form (32, 34, 37, 38), attempts express carboxyl end TS domain a <br />                                             catalytically active form unsuccessful. A genetic used assay TS <br />                                             function malarial DHFR-TS gene. E. coli cells lacking TS function (strain Rue10) <br />                                             normally proliferate presence thymidine absence thymidine (39). <br />                                             Lysates prepared Rue10 cells DHFR enzyme activity TS activity (data not <br />  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                            Page 5 <br />  <br />  <br />                                             shown). When Rue10 cells transformed expression plasmid coding full- <br />                                             length malarial DHFR-TS gene (Fig. 1A), E. coli Rue10 proliferate absence of <br />                                             thymidine (Fig. 1B). Transformation plasmids coding minimal 30-kDa &#226;&#8364;&#339;TS <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             domain&#226;&#8364;? (Fig. 1A) 40-kDa protein coding joining region the <br />                                             TS domain (Fig. 1A) failed rescue Rue10 thymidine dependence (Fig. 1B). These <br />                                             experiments suggested carboxyl end TS domain, defined sequence homology to <br />                                             monofunctional TS proteins, sufficient express functional TS protein. <br />  <br />                               Partial 5&#226;&#8364;&#178;-Deletion Malarial DHFR-TS Abolishes TS Function <br />                                             In order define minimum 5&#226;&#8364;&#178;-end functional TS domain, full-length malarial <br />                                             DHFR-TS gene subjected unidirectional exonuclease III treatment varying <br />                                             durations (Fig. 2A). The resulting fragments blunt-ended cloned recipient <br />                                             expression vector equipped blunt-ended AUG start codon. The ligation mixes <br />                                             time point transformed E. coli Rue10(DE3) scored TS function <br />                                             (colonies growing thymidine) malarial DHFR function (colonies growing in <br />                                             presence trimethoprim). The results showed following: (i) DHFR TS function <br />                                             lost simultaneously (Fig. 2B); (ii) colony survived plates without <br />                                             thymidine, replica plated, malarial DHFR function TS function (data not <br />                                             shown); (iii) DNA sequencing inserts TS+ E. coli showed intact <br />                                             malarial DHFR-TS gene (data shown). Control experiments confirmed repeated <br />                                             recovery just full-length DHFR-TS inability digest gene high <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             processivity exonuclease. In early 5&#226;&#8364;&#178;-digestion experiment, degradation <br />                                             malarial DHFR-TS gene visualized directly agarose gel (data shown). <br />                                             Intermediate sized fragments appropriate length observed DHFR-TS had <br />                                             treated exonuclease 5&#226;&#8364;&#8220;20 min (see schematic Fig. 2A). Additionally, selection <br />                                             transformants presence thymidine allowed recovery inserts incomplete <br />                                             DHFR-TS fragments (data shown). These experiments consistent the <br />                                             hypothesis &#226;&#8364;&#339;carboxyl end TS domain&#226;&#8364;? malarial parasites adequate to <br />                                             obtain functional TS enzyme. Furthermore, exonuclease experiment suggested the <br />                                             amino end malarial DHFR-TS necessary TS function. <br />  <br />                               DHFR Domain Can Activate TS Domain Trans <br />                                             To test directly contributions malarial DHFR domain TS function, E. coli <br />                                             Rue10 transformed 40-kDa carboxyl TS domain supplemented 27- <br />                                             kDa DHFR domain trans selected medium lacking thymidine. The results showed <br />                                             simultaneous transformation ThyA&#226;&#710;&#8217; E. coli expression vector coding <br />                                             40-kDa TS domain expression vector coding amino end DHFR fully <br />                                             rescued TS defect (Fig. 3). The plasmids introduced order (data <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             shown). Polymerase chain reaction analysis demonstrated TS function truly <br />                                             restored genes acting trans. There distinct plasmids rescued E. coli, <br />                                             evidence new bifunctional gene created recombination <br />                                             plasmids (data shown). Direct biochemical TS assay cell lysates showed <br />                                             that, expected, double transformed E. coli proliferated thymidine <br />                                             expressed active TS enzyme (data shown). These experiments demonstrated <br />                                             unambiguously amino-terminal DHFR domain malarial DHFR-TS necessary <br />                                             carboxyl-terminal TS sequence gain TS function. Since TS31 domain could <br />                                             rescued DHFR domain (data shown), &#226;&#8364;&#339;joining region&#226;&#8364;? make <br />                                             significant contacts malarial DHFR domain. The requirement DHFR domain <br />                                             species-specific endogenous E. coli DHFR activate malarial TS <br />                                             sequence expressed bacterial host. <br />  <br />  <br />  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                              Page 6 <br />  <br />  <br />                               Physical Associations Split Protein <br />                                             There general ways malarial DHFR domain activating TS <br />                                             function TS domain: (i) DHFR domain acted transient chaperon <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             folding TS sequence, (ii) DHFR domain formed stable <br />                                             association carboxyl-terminal TS. To determine stable association <br />                                             DHFR TS domains split protein, physical characteristics the <br />                                             active proteins double transformed E. coli studied. First, cell lysate E. <br />                                             coli Rue10(DE3) pET-DHFR, pET-TS40, subjected gel filtration chromatography. <br />                                             TS activity malarial DHFR emerged single superimposing peak (Fig. 4A). The size <br />                                             TS + DHFR complex 140,000 daltons. This consistent hypothesis <br />                                             DHFR TS fragments assembled tetramer 40-kDa TS <br />                                             units 27-kDa DHFR units, reestablishing natural relationship between <br />                                             domains. All reasonable alternative structures inconsistent gel filtration data. <br />                                             A free DHFR domain mass 27 kDa seen gel filtration column. We <br />                                             did DHFR-free obligate TS dimer mass 80 kDa. <br />  <br />                                             Since TS + DHFR split protein formed complex stable survive gel filtration <br />                                             chromatography, chose purify complex homogeneity study physical <br />                                             characteristics. Cell lysates double-transformed E. coli Rue10(DE3) passed <br />                                             methotrexate affinity column, known bind malarial DHFR domain <br />                                             (32). All unbound protein eluted 500 mM salt, specifically bound protein was <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             eluted 4 mM dihydrofolate (Fig. 4B). Both TS activity malarial DHFR <br />                                             activities eluted simultaneously 4 mM dihydrofolate fractions. The active fractions <br />                                             concentrated subjected SDS-polyacrylamide gel electrophoresis (Fig. 4C). <br />                                             Coomassie Blue staining revealed bands, mass 40 kDa a <br />                                             mass 27 kDa. Careful densitometry revealed 27- 40-kDa bands were <br />                                             present stoichiometric ratio 1 0.97, compensating size differences. The <br />                                             larger 40-kDa band labeling radioactive 5-fluoro-2&#226;&#8364;&#178;-deoxyuridylate one <br />                                             predict catalytically active TS domain (Fig. 4C). The smaller band, 27-kDa, <br />                                             shown malarial DHFR domain Western blotting (Fig. 4C). The final purified <br />                                             material DHFR-specific activity 39.2 &#206;&#188;mol/min/mg total protein. Assuming a <br />                                             kcat 1800/min DHFR, consistent protein having 27-kDa <br />                                             DHFR subunits attached 40-kDa TS subunits. In sum, physical characteristics of <br />                                             purified split protein support gel filtration studies consistent model <br />                                             DHFR TS domains assemble form 140-kDa tetramer. These <br />                                             experiments interactions DHFR domain TS domain that <br />                                             lead activation TS function transient; split malarial DHFR domain the <br />                                             40-kDa domain reassemble form stable complex reflects natural state the <br />                                             bifunctional protein (Fig. 5). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             The present study uses combination genetic biochemical approaches demonstrate <br />                                             species-specific interactions malarial DHFR domain TS domain are <br />                                             essential TS function. <br />  <br />                                             Although malarial DHFR-TS structure available, crystal structure Leishmania <br />                                             major DHFR-TS bifunctional protein offers obvious clue amino end the <br />                                             DHFR domain act determinant TS function. The Leishmania enzyme 22- <br />                                             amino acid extension amino terminus DHFR domain encircles the <br />                                             attached TS domain (28). At least, polypeptide extension amino end of <br />                                             DHFR domain appears necessary stabilize tertiary structure TS domain, but <br />                                             conceivable residues extended polypeptide contribute directly <br />                                             formation TS-active site. Whereas malarial DHFR shorter extension <br />                                             amino end (21), conceivable directly interacts residues TS <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                                             Page 7 <br />  <br />  <br />                                             domain necessary form catalytically active TS enzyme. Of course, also <br />                                             possible that, unlike Leishmania bifunctional protein, amino end malarial <br />                                             DHFR domain necessary primarily stabilize DHFR tertiary structure this, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             indirectly, influences correct folding activity malarial TS domain. <br />  <br />                                             Regardless mechanistic details underlying activation TS domain amino <br />                                             end DHFR domain, inhibition species-specific protein-protein interactions <br />                                             offer powerful new strategy selective chemotherapy malaria possibly <br />                                             protozoan parasites. Small molecular weight peptidomimetics disrupt the <br />                                             interactions domains fail activate TS expected inhibit malarial TS <br />                                             selectivity human TS does require &#226;&#8364;&#339;activation&#226;&#8364;? accessory protein. <br />                                             There precedence drug development inspired species-specific protein-protein <br />                                             interactions. For instance, virus-specific interactions subunits of <br />                                             ribonucleotide reductase herpes simplex virus led selective peptidomimetic <br />                                             inhibitors effective nanomolar concentrations (40). In addition, inhibition of <br />                                             protein-protein interactions considered systems including dimerization of <br />                                             HIV proteases, assembly herpes simplex virus DNA polymerase subunits, interactions <br />                                             involving G-proteins signal transduction machinery, binding adhesion molecules <br />                                             surface proteins platelets (41). <br />  <br />                                             The present E. coli genetic assay malarial TS function expected play powerful role <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             future mutagenesis experiments help establish contact sites two <br />                                             malarial protein domains. In addition, present genetic serve high <br />                                             throughput screens identify selective inhibitors malarial TS function. Finally, the <br />                                             present &#226;&#8364;&#339;two-hybrid&#226;&#8364;? genetic provides novel means maintaining plasmids <br />                                             indefinitely selectable drug marker. <br />  <br />                               Acknowledgments <br />                                             P. K. R. grateful Chen-Chen Kan (Agouron Pharmaceuticals) E. coli Rue10 cells, John Hyde <br />                                             (University Manchester) full-length DHFR-TS gene, Dan Herschlag, (Stanford University) for <br />                                             valuble discussions. <br />  <br />  <br />                               References <br />                                             1. Oaks, SC., Jr; Mitchell, VS.; Pearson, GW.; Pearson, CCJ., editors. Malaria. National Academy <br />                                                Press; Washington, D. C: 1991. <br />                                             2. White NJ. J Antimicrob Chemother. 1992; 30:571&#226;&#8364;&#8220;585. [PubMed: 1493976] <br />                                             3. Su XZ, Kirkman LA, Fujioka H, Wellems TA. Cell. 1997; 91:593&#226;&#8364;&#8220;603. [PubMed: 9393853] <br />                                             4. Rathod PK, McErlean T, Lee PC. Proc Natl Acad Sci U S A. 1997; 94:9389&#226;&#8364;&#8220;9393. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                9256492] <br />                                             5. White NJ, Olliaro PL. Parasitol Today. 1996; 12:399&#226;&#8364;&#8220;401. [PubMed: 15275291] <br />                                             6. Hillcoat BL, Blakely RL. J Biol Chem. 1966; 241:2995&#226;&#8364;&#8220;3001. [PubMed: 4957970] <br />                                             7. Hitchings GH. Clin Pharmacol Ther. 1960; 1:570&#226;&#8364;&#8220;589. <br />                                             8. Houghton PJ, Germain GS, Hazelton BJ, Pennington JW, Houghton JA. Proc Natl Acad Sci U S A. <br />                                                1989; 86:1377&#226;&#8364;&#8220;1381. [PubMed: 2537495] <br />                                             9. Ingraham HA, Dickey L, Goulian M. Biochemistry. 1986; 25:3225&#226;&#8364;&#8220;3230. [PubMed: 3524674] <br />                                             10. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, Wataya <br />                                                  Y. J Biol Chem. 1987; 262:8235&#226;&#8364;&#8220;8241. [PubMed: 2954951] <br />                                             11. Hitchings GH. Clin Pharmacol Ther. 1960; 1:570&#226;&#8364;&#8220;589. <br />                                             12. Russel PB, Hitchings GH. J Am Chem Soc. 1951; 73:3763&#226;&#8364;&#8220;3770. <br />                                             13. Spinks A, Tottey MM. Ann Trop Med. 1945; 39:220&#226;&#8364;&#8220;224. <br />  <br />  <br />  <br />  <br />                                                  J Biol Chem. Author manuscript; available PMC 2013 October 07. <br />                             Shallom et al.                                                                                             Page 8 <br />  <br />  <br />                                             14. Foote SJ, Galatis D, Cowman AF. Proc Natl Acad Sci U S A. 1990; 87:3014&#226;&#8364;&#8220;3017. [PubMed: <br />                                                 2183221] <br />                                             15. Peterson DS, Milhous WK, Wellems TE. Proc Natl Acad Sci U S A. 1990; 87:3018&#226;&#8364;&#8220;3022. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 [PubMed: 2183222] <br />                                             16. Nzila-Mounda A, Mberu EK, Sibley CH, Plowe CV, Winstanley PA, Watkins WM. Antimicrob <br />                                                 Agents Chemother. 1998; 42:164&#226;&#8364;&#8220;169. [PubMed: 9449279] <br />                                             17. Canfield CJ, Milhous WK, Ager AL, Rossan RN, Sweeney TR, Lewis NJ, Jacobus DP. Am J Trop <br />                                                 Med Hyg. 1993; 49:121&#226;&#8364;&#8220;126. [PubMed: 8352384] <br />                                             18. Winstanley PA, Mberu EK, Szwandt IS, Breckenridge AM, Watkins WM. Antimicrob Agents <br />                                                 Chemother. 1995; 39:948&#226;&#8364;&#8220;952. [PubMed: 7786001] <br />                                             19. Hekmat-Nejad M, Rathod PK. Exp Parasitol. 1997; 87:222&#226;&#8364;&#8220;228. [PubMed: 9371087] <br />                                             20. Rathod PK, Reshmi S. Antimicrob Agents Chemother. 1994; 38:476&#226;&#8364;&#8220;480. [PubMed: 8203840] <br />                                             21. Bzik DJ, Li W, Horii T, Insulburg J. Proc Natl Acad Sci U S A. 1987; 84:8360&#226;&#8364;&#8220;8364. [PubMed: <br />                                                 2825189] <br />                                             22. Beverley SM, Ellenberg TE, Cordingley JS. Proc Natl Acad Sci U S A. 1986; 83:2584&#226;&#8364;&#8220;2588. <br />                                                 [PubMed: 3458220] <br />                                             23. Chen G, Zolg JW. Mol Pharmacol. 1987; 32:723&#226;&#8364;&#8220;730. [PubMed: 3320742] <br />                                             24. Garrett CE, Coderre JA, Meek TD, Garvey EP, Claman D, Beverly SM, Santi DV. Mol Biochem <br />                                                 Parasitol. 1984; 11:257&#226;&#8364;&#8220;265. [PubMed: 6749182] <br />                                             25. Huennekans FM. Protein Sci. 1996; 5:1201&#226;&#8364;&#8220;1208. [PubMed: 8762155] <br />                                             26. Carreras CW, Santi DV. Annu Rev Biochem. 1995; 64:721&#226;&#8364;&#8220;762. [PubMed: 7574499] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             27. Meek TD, Garvey EP, Santi DV. Biochemistry. 1985; 24:678&#226;&#8364;&#8220;686. [PubMed: 3922404] <br />                                             28. Knighton RR, Kan CC, Howland E, Janson CA, Hostomska Z, Welsh KM, Mathews DA. Nat <br />                                                 Struct Biol. 1994; 1:186&#226;&#8364;&#8220;194. [PubMed: 7656037] <br />                                             29. Elcock AH, Potter MJ, Matthews DA, Knighton DR, McCammon JA. J Mol Biol. 1996; 262:370&#226;&#8364;&#8220; <br />                                                 374. [PubMed: 8845002] <br />                                             30. Trujillo M, Donald RG, Roos DS, Greene PJ, Santi DV. Biochemistry. 1996; 35:6366&#226;&#8364;&#8220;6374. <br />                                                 [PubMed: 8639582] <br />                                             31. Hekmat-Nejad M, Rathod PK. Antimicrob Agents Chemother. 1996; 40:1628&#226;&#8364;&#8220;1632. [PubMed: <br />                                                 8807052] <br />                                             32. Hekmat-Nejad M, Lee P, Rathod PK. Exp Parasito <br /> </body></html>